These single‐mutant NOG/APP (NA) and double‐mutant NOG/APP/PS1 (NAPS) KI mice exhibited clinically relevant AD pathologies, including intraneuronal amyloid deposits, microgliosis, and broad neuronal loss. Here, APP is linked to Alzheimer disease.